ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1428

Ankylosing Spondylitis Related Mortality Trends in USA from 1999-2020: Analysis of CDC Wonder Database

Sanjana Thimmannagari1, Shiamak Cooper2, Asim Khanfar1 and Candrika Dini Khairani1, 1Rochester General Hospital, Rochester, NY, 2Rochester General Hospital, Irondequoit, NY

Meeting: ACR Convergence 2025

Keywords: Ankylosing spondylitis (AS), Mortality

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1405–1433) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Ankylosing spondylitis is a significant cause of mortality and morbidity in the United States (US), with a prevalence of 0.2%–0.5%. However, trends in mortality among patients with ankylosing spondylitis in the US remain unclear. Therefore, we aim to analyze mortality trends in patients with ankylosing spondylitis in the US from 1999 to 2020, stratified by year, sex, and rural-urban status.

Methods: Age-adjusted mortality rates (AAMR) per 100,000 individuals were obtained from the Centers of Disease Control and Prevention WONDER database from the years of 1999-2020. Joinpoint regression was applied to calculate the annual percentage change (APC) to evaluate significant differences in the change of AAMR over time.

Results: A total of 4405 deaths occurred in patients with Ankylosing Spondylitis from 1999 to 2020. The AAMR declined from 1999 to 2004 (APC -7.96 [-23.02, -1.43]) and remained stable from 2004 to 2020 (APC 0.44 [-0.95, 8.57]). Among females, AAMRs were stable from 2002 to 2020 (APC 2.51 [-0.99, 6.68]). Among males, the AAMR declined from 1999 to 2004 (APC -7.56 [-18.71, -2.31]) and remained stable from 2004 to 2020 (APC -0.73 [-1.76, 4.68]). The AAMR in urban areas declined from 1999 to 2004 (APC -9.46 [-25.62, -1.70]) and remained stable from 2004 to 2020 (APC 0.69 [-0.99, 9.63]). In rural areas, the AAMR declined from 1999 to 2012 (APC -3.60 [-11.60, -1.57]) and then increased from 2012 to 2020 (APC 4.01 [-0.001, 18.745]).

Conclusion: From 1999 to 2020, ankylosing spondylitis mortality initially declined but later plateau. Mortality rates remained constant in females and urban areas, while rural areas had increased mortality after 2012. These potential disparities warrant further research into quality of care delivered and phenotype of disease based on sex and rural status.

Supporting image 1Annual Percentage Change in Ankylosing Spondylitis-Related Mortality by Year and Gender

Supporting image 2Annual Percentage Change in Ankylosing Spondylitis-Related Mortality by Urban Status


Disclosures: S. Thimmannagari: None; S. Cooper: None; A. Khanfar: None; C. Khairani: None.

To cite this abstract in AMA style:

Thimmannagari S, Cooper S, Khanfar A, Khairani C. Ankylosing Spondylitis Related Mortality Trends in USA from 1999-2020: Analysis of CDC Wonder Database [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/ankylosing-spondylitis-related-mortality-trends-in-usa-from-1999-2020-analysis-of-cdc-wonder-database/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ankylosing-spondylitis-related-mortality-trends-in-usa-from-1999-2020-analysis-of-cdc-wonder-database/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology